Close
FINDING CURES TOGETHER<sup>SM</sup>
Phillip A. Sharp, PhD

Chairperson
Phillip A. Sharp, PhD
Institute Professor; David H. Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
Cambridge, Massachusetts

Arnold J. Levine, PhD

Vice Chairperson
Arnold J. Levine, PhD
Professor
Institute for Advanced Study and Cancer Institute of New Jersey
Princeton, New Jersey

William G. Nelson, MD, PhD

Vice Chairperson
William G. Nelson, MD, PhD
Director
Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University
Baltimore, Maryland

Julian Adams, PhD

Julian Adams, PhD
President of Research and Development
​Infinity Pharmaceuticals Inc.
Cambridge, Massachusetts

Carlos L. Arteaga, MD

Carlos L. Arteaga, MD
Director, Center for Cancer Targeted Therapies; Director, Breast Cancer Program; Associate Director for Clinical Research
​Vanderbilt-Ingram Cancer Center
Nashville, Tennessee

Frederick R. Appelbaum, MD

Frederick R. Appelbaum, MD

Director, Clinical Research Division Fred Hutchinson Cancer Research Center Head, Division of Oncology University of Washington School of Medicine President, Seattle Cancer Care Alliance
​Seattle, Washington

Alan Bernstein, PhD

Alan Bernstein, PhD
President and CEO
​Canadian Institute for Advanced Research (CIFAR)
Toronto, Ontario, Canada

Elizabeth H. Blackburn, PhD

Elizabeth H. Blackburn, PhD
President
The Salk Institute for Biological Studies
La Jolla, California

Judy E. Garber, MD, MPH

Judy E. Garber, MD, MPH
Director, Center for Cancer Genetics and Prevention
​Dana-Faber Cancer Institute
Boston, Massachusetts

Richard B. Gaynor, MD

Richard B. Gaynor, MD
Vice President, Clinical Development and Medical Affairs
Eli Lilly and Company
Indianapolis, Indiana

Nancy F. Goodman, JD

Advocate
Nancy F. Goodman, JD
Founder and Executive Director
​Kids v. Cancer
Washington, District of Columbia

William N. Hait, MD, PhD

William N. Hait, MD, PhD
Global Head, Research and Development
Janssen, Pharmaceutical Companies of Johnson & Johnson
Raritan, New Jersey

Lee J. Helman, MD

Lee J. Helman, MD
Scientific Director for Clinical Research, Center for Cancer Research
​National Cancer Institute
Bethesda, Maryland

Waun Ki Hong, MD

Waun Ki Hong, MD
Head, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas

William G. Kaelin Jr., MD

William G. Kaelin Jr., MD
Professor
Dana-Farber Cancer Institute
Boston, Massachusetts

Michael B. Kastan, MD, PhD

Michael B. Kastan, MD, PhD
Executive Director
Duke Cancer Institute
Durham, North Carolina

Richard D. Kolodner, PhD

Richard D. Kolodner, PhD
Professor of Medicine
University of California, San Diego Ludwig Institute for Cancer Research
La Jolla, California

Guillermina (Gigi) Lozano, PhD

Guillermina (Gigi) Lozano, PhD
Chairman and Professor, Department of Genetics
The University of Texas MD Anderson Cancer Center
Houston, Texas

Tak W. Mak, PhD

Tak W. Mak, PhD
Director
Campbell Family Institute for Breast Cancer Research Princess Margaret Hospital
Toronto, Ontario,  Canada

Cecil B. Pickett, PhD

Cecil B. Pickett, PhD
President, Research and Development
Biogen Idec
Cambridge, Massachusetts

Arlene H. Sharpe, MD, PhD

Arlene H. Sharpe, MD, PhD
George Fabyan Professor of Comparative Pathology, Microbiology and Immunobiology
​Harvard Medical School
Boston, Massachusetts

Laura K. Shawver, PhD

Laura K. Shawver, PhD
Chief Executive Officer
Cleave Biosciences
Burlingame, California

Ellen V. Sigal, PhD

Advocate
Ellen V. Sigal, PhD
Chairperson and Founder
Friends of Cancer Research (Friends)
Washington, District of Columbia

David A. Tuveson MD, PhD

David A. Tuveson MD, PhD
Director of Research, the Lustgarten Foundation Roy J. Zuckerberg Professor of Cancer Research
​Cold Spring Harbor Laboratory
Cold Spring Harbor, New York